Juvenile xanthogranuloma is usually self-limiting with skin lesions regressing in 3–6 years. Even systemic JXG resolves spontaneously in most cases. Skin lesions of juvenile …

2023年8月8日 · Juvenile xanthogranuloma (JXG) is a non-Langerhans cell histiocytosis and is fairly common, often affecting infants and young children. Cutaneous lesions usually resolve …

This report synthesizes the overlapping pathogenetic mechanism and phenotype of two RASopathies, NS and NF1, integrates the molecular mechanism of JXG and suggests a …

We describe a patient with extensive cutaneous nodular JXG who developed hyperlipidemia in association with resolution of his lesions during his first few months of life. After the lesions …

Bone and skin biopsies confirmed the findings. Symptoms have resolved since maintenance chemotherapy, which included vincristine, dexamethasone, 6-mercaptopurine, and …

2022年12月30日 · At 1.5 years old, the lesion had flattened. By 3 years old, the lesion had resolved but left a hyperpigmented patch with a scar at the punch biopsy site. Our case …

At 1.5 years old, the lesion had flattened. By 3 years old, the lesion had resolved but left a hyperpigmented patch with a scar at the punch biopsy site. Our case represents a congenital …

2022年7月31日 · JXG is a self-limited disorder and skin lesions usually resolve spontaneously within 3-6 years, which means treatment is not required in most cases. 1-3 Occasionally, …

2013年6月25日 · Juvenile xanthogranuloma (JXG) is a non-Langerhans histiocytosis occurring predominantly in infancy and early childhood. Resolution usually occurs over a period of …

The authors here describe the first case of spontaneous resolution of an intramedullary spinal cord lesion of JXG associated with cerebral and cutaneous lesions in a young boy with 9 years …